Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 1 Interventional

Enzalutamide Implants (Enolen) in Patients With Prostate Cancer

ClinicalTrials.gov ID: NCT06257693

Public ClinicalTrials.gov record NCT06257693. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 29, 2026, 4:18 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1 Study to Establish the Feasibility of Enolen (tm) for the Local Delivery of Enzalutamide in Patients With Prostate Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The study is to assess whether the Enolen is safe and delivers anti-androgen medication locally in patients that are planning for radical prostatectomy.

Study identification

NCT ID
NCT06257693
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 1
Lead sponsor
Alessa Therapeutics Inc.
Industry
Enrollment
45 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
21 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 20, 2024
Primary completion
Dec 29, 2028
Completion
Dec 29, 2028
Last update posted
Aug 10, 2026

2024 – 2028

United States locations

U.S. sites
10
U.S. states
8
U.S. cities
10
Facility City State ZIP Site status
Urology Associates of Central California Fresno California 93720 Recruiting
University of California San Francisco Helen Diller Family Comprehensive Cancer Center San Francisco California 94158 Recruiting
Northwestern University Chicago Illinois 60611 Recruiting
Mary Bird Cancer Center Metairie Louisiana 70002 Recruiting
Johns Hopkins University School of Medicine Baltimore Maryland 21287 Recruiting
National Institutes of Health Clinical Center Bethesda Maryland 20892 Recruiting
VA Portland Health Care System Portland Oregon 97239 Recruiting
Atlantic Urology Specialists Myrtle Beach South Carolina 29572 Recruiting
Virginia Commonwealth University Richmond Virginia 23298 Recruiting
Aurora Urology Milwaukee Wisconsin 53215 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06257693, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 10, 2026 · Synced Sep 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06257693 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →